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CASE REPORTS
Relapsing melioidosis as cause of iliac mycotic
aneurysm: An indigenous case in Taiwan
Chwan-yau Luo, MD,a Wen-Chien Ko, MD,b Hsin-Chun Lee, MD,b and Yu-Jen Yang, MD, PhD,a
Tainan, Taiwan
Melioidosis, an infectious disease caused by Burkholderia pseudomallei, an aerobic gram-negative bacillus, is normally
transmitted through skin wounds and contact with infected human beings and animals. Its primary source is rice paddy
soil and stagnant water. Melioidosis manifesting as an arterial mycotic aneurysm is rare, and, to our knowledge, infected
true and false aneurysms of the iliac artery have never been reported. We report the case of a patient without contact with
the normal sources of infection in whom an iliac mycotic aneurysm was caused by relapsing melioidosis and treated with
an extra-anatomic bypass graft. (J Vasc Surg 2003;37:882-5.)
Melioidosis is a granulomatous infectious disease of
both animals and human beings that is caused by Burkhold-
eria pseudomallei (formerly Pseudomonas pseudomallei), an
aerobic gram-negative bacillus.1-3 Normally found in rice
field soil and stagnant water within 20 degrees of latitude
north and south of the equator, especially in Southeast Asia
and northern Australia, B pseudomallei is occasionally
found elsewhere in the world,1-6 most often in patients who
have lived in these disease-endemic areas. Taiwan is not
within the endemic area, but our laboratory staff have been
trained to recognize this bacillus. Its clinical manifestations
are diverse and include localized abscess, pneumonia, or
severe fatal septicemia.2 Melioidosis manifesting as an arte-
rial mycotic aneurysm is rare, and infected true and false
aneurysms of the iliac artery have, to our knowledge, never
been reported. We report the case of a patient with an iliac
mycotic aneurysm caused by relapsing melioidosis. Only
four other cases of infected pseudoaneurysm caused by this
bacterium have been reported.7-10 We report our manage-
ment of this problematic situation and the destructive
nature of the relapsing infection caused by this virulent
organism.
CASE REPORT
A 67-year-old woman with an unidentified history of diabetes
mellitus visited our emergency department with a 1-week history
of fever of unknown origin and changes in mental status over the
previous few days. The patient was not a rice farmer, nor had she
had any obvious heavy exposure to soil, and she had not traveled
overseas. On admission, her temperature was 39° C orally. The
patient appeared acutely ill. Physical examination revealed a crack-
ling sound in her left lung during breathing; all other findings were
unremarkable. Her white blood cell count was elevated at 20,000/
mm3, with 5% band forms, 89% neutrophils, 3% lymphocytes, and
2% monocytes. Blood glucose concentration was 428 mg/dL, and
C-reactive protein was 395 mg/dL. A left lower lobe mass was
revealed at chest radiography. A chest computed tomography (CT)
scan showed left lower lobe pneumonia with abscess, and bron-
choscopy was performed to rule out obstructive pneumonitis. A
blood culture grew gram-negative bacilli identified as B pseudoma-
llei with a commercial identification system (API ZONE; Bi-
oMerieux, Hazelwood, Mo), which in vitro is susceptible to -lac-
tam antibiotics. Despite intravenous administration of piperacillin
and tazobactam, spiking fever persisted. The medication was soon
changed to intravenous ceftazidime (2 g q8H) and oral co-trimox-
azole (sulfamethoxazole, 800 mg, plus trimethoprim, 160 mg,
q12h). After 2 weeks of treatment the patient was discharged with
a maintenance regimen of oral co-trimoxazole (800/160 mg q8h)
and amoxicillin-clavulanate (375 mg q8h). Fourteen days later,
however, she was readmitted with fever and cellulitis of the left
lower leg. Relapse of bacteremic melioidosis was confirmed. Intra-
venous ceftazidime (2 g q8h) and a higher dose of oral co-
trimoxazole (1200/240 mg q12h) were administered. The patient
was discharged after a 2-week course of treatment, with mainte-
nance therapy including oral co-trimoxazole (1200/240 mg q8h)
and amoxicillin-clavulanate (375 mg q8h).
Two months later the patient returned to our emergency
department after 2 consecutive days of nausea and vomiting. A
contrast medium-enhanced abdominal CT scan showed a low-
density mass approximately 2.5 cm in diameter, without ring
enhancement, beyond the intimal calcification, over the junction
of the terminal abdominal aorta and left common iliac artery (Fig
1). A magnetic resonance imaging angiograph also demonstrated a
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typical saccular aneurysm in the left common iliac artery (Fig 2),
supporting a diagnosis of mycotic aneurysm. Intravenous ceftazi-
dime (2 g q8h) and co-trimoxazole (1200/240 mg q8h) were
administered immediately. The infected aneurysm was resected
and the left common iliac artery oversewn proximally and distally,
followed immediately by aggressive debridement of the surround-
ing infected tissue. Because of the particularly virulent bacterium
and recurrent nature of melioidosis, distal blood flow was restored
with a femoral-femoral extra-anatomic bypass graft (Hemashield;
Boston Scientific Medi-Tech, Wayne, NJ). At surgery the pseudo-
aneurysm was seen to arise from the right posterolateral aspect of
the left common iliac artery. There was induration, thickening, and
inflammation of the wall of the pseudoaneurysm, but no pus. The
iliac artery wall showed atherosclerosis with plaque and calcifica-
tion. Microscopic examination of the resected specimen also dem-
onstrated acute and chronic inflammatory cell infiltration. Cultures
of pseudoaneurysm and para-aneurysm necrotic tissue obtained
during surgery yielded B pseudomallei. On the basis of minimum
inhibitory concentration (MIC) showing resistance and suscepti-
bility levels of 12 possible antibiotics against B pseudomallei, we
selected 4 that showed the highest susceptibility. After treatment
for 4 weeks with intravenous ceftazidime and 2 weeks with intra-
venous co-trimoxazole, the patient was discharged without any
symptoms. Oral co-trimoxazole (1200/240 mg q8h), minocycline
(100 mg q12h), and ampicillin-sulbactam (1000/500 mg q12h)
were prescribed as maintenance therapy for 6 months after dis-
charge. Eight months later the patient was well, without clinical or
radiologic evidence of infection.
DISCUSSION
Melioidosis was first reported in Taiwan in 1985 in a
patient who contracted the disease in the Philippines,11 and
the disease has recently become an emergent infection in
Taiwan.12-14 At least 17 cases have been reported since
1985, most after 1994, and 13 (76%) were considered
indigenous.15 As in our patient, sporadic indigenous infec-
tion is likely. Moreover, 3 additional cases have recently
been found in nearby areas, and recent local reported data
suggest that Taiwan should be considered an area endemic
for melioidosis, in addition to China, Australia, and South-
east Asia. B pseudomallei infection should be suspected in
any visitor to Taiwan who had heavy exposure to rice
paddies and stagnant water with subsequent development
of sepsis and fever of unknown origin.
Melioidosis, like many other diseases, is also known for
its diverse clinical manifestations, and for the past decade
and a half in Asia it has been labeled “the great mimicker”
in both the medical literature2 and the Asian popular
press.16 It is most often contracted when the skin is cut or
punctured in soil containing the bacillus. It can also be
transmitted by contact with infected animals and human
beings, and rarely by ingestion or inhalation. Its manifesta-
tions range from localized abscess to severe community-
acquired pneumonia to fatal septicemia.1-3,15 In patients
with septicemia at presentation, mortality may be as high as
40% to 90% if antibiotic therapy is not appropriately admin-
istered.10,17 Involvement with the cardiovascular system
resulting in mycotic aneurysm is rare; there are only 4 other
reported cases, involving the thoracoabdominal aorta,7 ab-
dominal aorta,8 renal artery,9 and subclavian artery, respec-
tively.10 Involvement of the iliac artery with recurrent
melioidosis has never been reported.
An intra-abdominal iliac mycotic aneurysm is still a
problem for the cardiovascular surgeon. Traditional treat-
ment has included resection of the infected pseudoaneu-
rysm and restoration of distal blood flow with in situ
reconstruction or placement of an extra-anatomic bypass
graft. Although treating intra-abdominal infected aortic
aneurysm with resection, aggressive debridement, and re-
construction with an in situ graft interposition wrapped and
protected by the great omentum has produced good re-
sults,18 we are nevertheless concerned because of the recur-
rent nature of melioidosis, which can become latent and
subject to relapse after years because of stress or illness. It
may be unwise to leave a prosthesis or allograft in such a
virulent, infectious tissue bed. In one case with proved B
pseudomallei infection, successful short-term results were
achieved with resection of the infected abdominal aortic
pseudoaneurysm and prosthetic graft interposition.8 No
long-term results have been reported. On the contrary, in
the first reported case7 of B pseudomallei-caused mycotic
Fig 1. Preoperative proximal (top) and distal (bottom) contrast
material-enhanced abdominal CT scans show a hypodense para-
iliac artery mass formation without ring enhancement (arrows).
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aneurysm in the thoracoabdominal aorta, the aneurysm,
treated only with antibiotic therapy without surgical re-
moval of the infectious nidus, eventually fatally ruptured.
In a third case,9 involving the renal artery, cure was
achieved after total nephrectomy and excision of the in-
fected pseudoaneurysm without any prosthesis in situ. In
the most recently reported case,10 infection in the right
subclavian artery relapsed violently 1 week after discontin-
uation of intravenous antibiotic therapy when recon-
structed with an in situ femoral vein interposition graft. The
patient recovered after removal of the disrupted vein graft
and aneurysm cavity. Oral amoxicillin-clavulanate was con-
tinued indefinitely. The authors concluded that autoge-
nous vein graft replacement of infected vessels may be
successful in most cases, but that this technique should not
be used when such a highly virulent bacillus is involved. We
concur with this strategy. In our patient, extra-anatomic
bypass grafting was performed after resection of the in-
fected pseudoaneurysm and aggressive debridement, and at
an 8-month follow-up the patient was well and infection-
free, even after discontinuation of oral antibiotic therapy.
Some investigators suggest that melioidosis is a facul-
tative intracellular infection. In vivo, -lactam antibiotics
do not penetrate intracellular sites and kill nonmultiplying
dormant bacteria, a possible reason for the frequent relapse
of melioidosis after treatment with these drugs.15,19 This
suggests that B pseudomallei is frequently resistant to many
antibiotics, including aminoglycosides and first-generation
or second-generation cephalosporins.15,19,20 Ceftazidime,
a third-generation cephalosporin, is the drug of choice to
treat acute melioidosis complicated with bacteremia or
pulmonary abscess. Twice our patient had bacteremia at
presentation, which resolved both times after 2 weeks of
parenteral ceftazidime and oral co-trimoxazole treatment.
Oral amoxicillin-clavulanate is usually recommended for
maintenance treatment of chronic melioidosis infection;
however, even when this therapy was combined with oral
co-trimoxazole, the disease relapsed twice in our patient,
with eventual development of a mycotic aneurysm for
which surgical intervention was required to eradicate the
complicated infectious nidus. We therefore changed our
maintenance therapy to co-trimoxazole in combination
with minocycline and ampicillin-sulbactam, both in vitro
active, for 6 months, after which the patient had no signs of
recurrent infection even after discontinuing oral medica-
tion. This suggests that for relapsing melioidosis, co-tri-
moxazole plus oral minocycline combined with ampicillin-
sulbactam is one alternative for chronic maintenance
therapy.
We thank Bill Franke for proofreading the manuscript
and editing our English.
Fig 2. Preoperative oblique view of magnetic resonance imaging angiograph demonstrates a saccular pseudoaneurysm
at the left common iliac artery (arrow).
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